ICRA assigns rating of Strides Arcolab’s bank facilities

07 Jul 2011 Evaluate

Credit rating agency, ICRA has assigned BBB- rating to the Rs 810.0 crore term loan facilities of Strides Arcolab. The rating agency has also assigned A3 rating to the Rs 125.0 crore short term loan facilities, Rs 250.0 crore fund based facilities and the Rs 135.0 crore non-fund based facilities of the company. The outlook on the long-term rating is stable.

The assigned ratings reflect the company’s strong focus in the niche sterile segment over the years, the traditional pharmaceutical business lending stability to revenues; its healthy track record of ANDA filings and robust product pipeline with large number of United States Food and Drug Administration (USFDA) approved products to be commercialized.

Strides Arcolab is a global pharmaceuticals company headquartered in Banglore, India that develops and manufactures wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

619.05 3.95 (0.64%)
15-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1705.15
Dr. Reddys Lab 1155.80
Cipla 1481.40
Lupin 2012.05
Zydus Lifesciences 884.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...